You searched for "ophthalmoscope"

3019 results found

Results of bilateral medial rectus recession combined with either BT or bridge Faden when treating large angle strabismus

In a series of 26 patients (11 female, 15 male) with large angle esotropia >35PD, the authors compared results of botulinum toxin A (BTA) and bridge Faden operation combined with bilateral medial rectus (BMR) recession. Overall age of surgery was...

Use of immunomodulatory treatment for non-infectious uveitis: an International

Two-hundred-and-twenty-one group members from 53 countries completed a questionnaire on their indications, investigations and use of conventional and biologics and follow-up of treated patients. Main indications to start systemic immunomodulatory drugs were: uveitis not controlled by oral prednisolone (94.1%), specific...

Developments in retinal pigmentation measurement and the hopes of an equitable future

Our AI & Oculomics co-editor, Nima Ghadiri, sat down with Abraham Olvera-Barrios from Moorfields and Anand Rajesh from the University of Washington to discuss their recent international study into retinal pigmentation and its wider clinical, technological and academic applications. Can...

Birmingham Optical welcomes Irem Ali as Chief Commercial Officer

She brings with her extensive experience across sales, marketing, and operations within the MedTech, healthcare, and pharmaceutical sectors. Commenting on her appointment, Irem said: “I am delighted to be joining a growing organisation at such a pivotal time. The team...

Three-year results of 0.01% and 0.1% loading dose atropine treatment including washout in Danish children with myopia: a placebo-controlled, randomised clinical trial

This was a placebo-controlled, double-blind, randomised clinical trial of 97 children to examine the safety and efficacy of low-dose atropine (0.1% and 0.01% loading dose) after 2-year treatment and 1-year washout in 6–12-year-old Danish children with myopia. Ninety-one children were...

Anti-VEGF injections and macular atrophy progression in patients with nAMD in remission

This is a retrospective study of 59 eyes with neovascuar age-related macular degeneration (nAMD) with at least 6-month remission, to determine the effect of continuing anti-VEGF injections on the progression of macular atrophy (MA) during remission of nAMD. Group 1...

MOS Annual Meeting 2026

Medical Ophthalmological Society's 27th Annual Meeting

VISION 2020 LINKS: Retinoblastoma 
in Africa

The VISION 2020 LINKS Programme is part of the ‘VISION 2020: The Right to Sight’ global initiative to eliminate avoidable blindness [1]. The LINKS Programme works with overseas eye departments to help identify priorities and match their priority needs with...

OBITUARY: James Finbarr (Barry) Cullen

On the sad passing of Eye News’ first editor and long-term contributor JF (Barry) Cullen, his friend Hector Chawla takes a look at the life and career of this effervescent character and giant of the ophthalmology world. Barry Cullen was...

My Top Five: Emerging technologies revolutionising ophthalmology

Advancements in ophthalmology have significantly transformed eyecare practices. This article explores five emerging technologies that are revolutionising the field, from virtual reality (VR) surgical training to novel therapies for corneal conditions. These innovations are reshaping how eyecare professionals diagnose, treat...

Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting

The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...

Non-organic visual loss

Patients can present to eye departments with various signs and symptoms (mostly symptoms) with no obvious organic cause. These patients can be labelled with any of a wide range of diagnoses such as functional visual loss, functional overlay, psychosomatic reaction...